Deployment of convalescent plasma for the prevention and treatment of COVID-19Evan M. Bloch, Aaron A.R. Tobian, Shmuel Shoham et al.|Journal of Clinical Investigation|2020Cited by 863
COVID-19 infection alters kynurenine and fatty acid metabolism, correlating with IL-6 levels and renal statusTiffany Thomas, Angelo D’Alessandro, Davide Stefanoni et al.|JCI Insight|2020Cited by 600
Effects of Red-Cell Storage Duration on Patients Undergoing Cardiac SurgeryMarie E. Steiner, Christopher P. Stowell, Paul M. Ness et al.|New England Journal of Medicine|2015Cited by 486
Evidence of Structural Protein Damage and Membrane Lipid Remodeling in Red Blood Cells from COVID-19 PatientsTiffany Thomas, Angelo D’Alessandro, Paul W. Buehler et al.|Journal of Proteome Research|2020Cited by 292
A randomized double-blind controlled trial of convalescent plasma in adults with severe COVID-19Max R. O’Donnell, W. Ian Lipkin, Beatriz Grinsztejn et al.|Journal of Clinical Investigation|2021Cited by 172